Lexie B3 vs Oticon More

The Lexie B3 is a behind-the-ear OTC hearing aid priced at $999 that earns an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #1 among the 65 OTC hearing aids we've evaluated, making it a standout performer in its category. In our standardized testing, the Lexie B3 demonstrates excellent speech-in-quiet performance at 4.5/5, scoring 1.73 points above the OTC category average of 2.79/5. Speech-in-noise results are more nuanced—while the 2.5/5 score sits 1.02 points above the category average of 1.48/5, this remains mixed in absolute terms. Music streaming quality is solid at 3.3/5, exceeding the category average by 1.38 points, and feedback handling is excellent at 4.6/5. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above the category average. The device uses a tulip dome coupling in both initial and tuned configurations, maintaining consistent performance across fitting conditions with identical normalized scores of 4.8/5 for both fits. For those considering alternatives, devices like the RxEars Rxi, Meta Ray-Ban Glasses (Gen 2), and Cearvol Wave offer lower price points, though with correspondingly lower SoundScores. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance who prioritize speech clarity in quieter environments and quality music streaming, and who can accommodate its mid-tier OTC price point.

The Oticon More is a premium behind-the-ear prescription hearing aid that earned an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 22% of the 36 prescription hearing aids we've evaluated. Released in 2021, this device remains competitive and has received HearAdvisor's Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrated strong speech clarity performance. Speech in quiet scored 4.0/5, which is 0.73 points above the category average—a notable margin that reflects genuine audibility advantages in everyday conversations. Speech in noise measured 2.7/5, which is above the category average by 0.75 points, though only mixed in absolute terms, meaning challenging listening environments may still require effort. Own-voice comfort scored a solid 3.1/5 (+0.35 vs category average), and music streaming measured 3.0/5 (+0.36 vs category average), both performing above typical prescription aids. Feedback handling scored 3.5/5, which is solid in absolute terms, though below the category average of 4.71/5 by 1.21 points—something to discuss with your hearing care provider. At $4,598, this is a premium-priced device offering iPhone and Android streaming, hands-free calling, and your choice of rechargeable or disposable batteries. The Oticon More is well-suited for those prioritizing speech clarity who want a proven performer from an established manufacturer. Competitors in this price range include the newer Oticon Intent (4.85/5) and Oticon Real (4.75/5), which may be worth comparing during your fitting appointment.